SCHEMBL7199251

SCHEMBL7199251

CC(=CC(N)c1ccc(C)cc1)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.41
CES2 O00748 1/20 0.40
CES1 P23141 1/20 0.40
LMNA P02545 5/20 0.39
ALDH1A1 P00352 4/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
NPC1 O15118 5/20 0.37
RAB9A P51151 5/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
MAPT P10636 4/20 0.37
HPGD P15428 2/20 0.37
PTGS2 P35354 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.35
HIF1A Q16665 1/20 0.35
POLB P06746 2/20 0.34
NFKB1 P19838 1/20 0.34
NFKB2 Q00653 1/20 0.34
RELA Q04206 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10433950 0.82 CES2 (0.42) KDM1ACES2CES1LMNAALDH1A1
SCHEMBL6547527 0.81 TRPA1 (0.47) KDM1ACES2CES1LMNAALDH1A1
SCHEMBL6546277 0.74 TRPA1 (0.51) CES2CES1LMNAALDH1A1SMN1; SMN2
SCHEMBL28218597 0.72 KDM1A (0.43) KDM1ACES2CES1LMNAMAPT
SCHEMBL563813 0.71 LMNA (0.45) LMNAALDH1A1HIF1A
SCHEMBL20082262 0.70 DPP4 (0.34) CES2CES1LMNAMAPT
SCHEMBL9806392 0.70 TRPA1 (0.41) KDM1ACES2CES1LMNAALDH1A1
SCHEMBL5967505 0.70 DPP4 (0.42) CES2CES1LMNAALDH1A1CYP2D6
SCHEMBL28806587 0.70 TRPA1 (0.41) KDM1ACES2CES1LMNAALDH1A1
SCHEMBL10945577 0.69 DEGS1 (0.46) KDM1ACES2LMNANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030088095-A1 Reacting an optically active imine with a hemiacetal of a perfluoroalkylaldehyde or a hydrate; hydrolyzing the condensate under an acid condition. CENTRAL GLASS COMPANY, LIMITED 2003-05-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030088095-A1 Reacting an optically active imine with a hemiacetal of a perfluoroalkylaldehyde or a hydrate; hydrolyzing the condensate under an acid condition. ADH1C, ADH1A, HPD KDM1A 3103/4885CES2 703/4885CES1 222/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.